BRD-73954

CAS No. 1440209-96-0

BRD-73954( BRD73954 )

Catalog No. M11867 CAS No. 1440209-96-0

The first HDAC6/8 dual inhibitor with IC50s of 36/120 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 45 In Stock
5MG 81 In Stock
10MG 136 In Stock
25MG 273 In Stock
50MG 412 In Stock
100MG 606 In Stock
500MG 1287 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BRD-73954
  • Note
    Research use only, not for human use.
  • Brief Description
    The first HDAC6/8 dual inhibitor with IC50s of 36/120 nM.
  • Description
    The first HDAC6/8 dual inhibitor with IC50s of 36/120 nM; show no significant inhibition for other HDAC isoforms (IC50>9 uM); robustly increase in α-tubulin acetylation, has no change in the acetylation state of H3 in Hela cells.
  • In Vitro
    BRD73954 (10 μM; 48 h; HeLa cells) inhibits HDAC6 activity via upregulation of Ac-Tubulin. Western Blot Analysis Cell Line:HeLa cells Concentration:10 μM Incubation Time:48 hours Result:Increased inα-tubulin acetylation, no change in the acetylation state of H3 was observed.
  • In Vivo
    ——
  • Synonyms
    BRD73954
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC2|HDAC4|HDAC6|HDAC8
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1440209-96-0
  • Formula Weight
    284.3098
  • Molecular Formula
    C16H16N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 35 mg/mL
  • SMILES
    C1=CC=C(C=C1)CCNC(=O)C2=CC(=CC=C2)C(=O)NO
  • Chemical Name
    1,3-Benzenedicarboxamide, N1-hydroxy-N3-(2-phenylethyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Olson DE, et al. J Med Chem. 2013 Jun 13;56(11):4816-20.
molnova catalog
related products
  • MPI_5a

    MPI_5a is an effective and selective inhibitor of HDAC6 (IC50=36 nM).

  • CUDC-101

    A potent, multi-targeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.

  • Remetinostat

    Remetinostat is a hydroxamic acid-based inhibitor of histone deacetylase enzymes.